Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

NCT04906928 · tracked via the Priya Life Science France tracker

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Phase

Observational

Started

2023-10-25

Last updated

2026-01-05

Condition(s) studied

Spinal Cord Injuries

Investigational drug(s) / intervention(s)

MRI

MRI: * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)

Study summary

* verification of inclusion and non-inclusion criteria
* information and collection of consent
* standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence.
* 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient over 18 years old * To benefit from a medullary exploration planned by 3T MRI as part of a first evaluation or a reassessment of inflammatory involvement of the nevrax * Express consent to participate in the study * Affiliate or beneficiary of a social security scheme Exclusion Criteria: * Patient benefiting from a legal protection measure * Pregnant, parturient or breastfeeding woman * Absolute or relative contraindication to MRI

Primary outcome measure(s)

estimate the number of lesions detected with the 3D FGAPSIR sequence and not detected with the 3D PSIR sequence. — 1 DAY
estimate the number of lesions detected with the 3D FGAPSIR sequence and not detected with the 3D PSIR sequence.

Trial sites (1)

Facility	City	Region	Status
Fondation Ophtalmologique Adolphe de Rothschild (FOR)	Paris	France	Recruiting

More Fondation Ophtalmologique Adolphe de Rothschild trials in France

Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France Recruiting

Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE) Recruiting

Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations Recruiting

Motivational Behavioral and Functional MRI Impairment in Patients With Chronic Neuropathic Pain Recruiting

Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months Recruiting

Other trials for the same condition

The Enteric Nervous System in Spinal Cord Injury: Study of the Enteric Nervous System and the Intestinal Epithelial Barrier Via Colonic Biopsies in Spinal Cord Injury Patients Recruiting

Self-balancing Personal Exoskeleton for SCI (WIP) Recruiting

Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population Recruiting

Assessment of the Efficacy and Safety of EESS in Patients With Incomplete Spinal Cord Injuries Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04906928 on ClinicalTrials.gov ↗ ← All trials in France